Expanded Farmer Access to Corteva’s Enlist® Herbicides Anticipated for 2024 Growing Season
INDIANAPOLIS, Dec. 1, 2023 /PRNewswire/ — After successfully completing a comprehensive Endangered Species Act (ESA) consultation process, Corteva Agriscience’s innovative Enlist® herbicides are poised for expanded use in formerly restricted counties in key growing regions across the U.
Notice – BRIDGING FINANCE INC., DAVID SHARPE, NATASHA SHARPE and ANDREW MUSHORE, File No. 2022-9
TORONTO, Dec. 1, 2023 /CNW/ – The previously scheduled day of December 4, 2023 will not be used for the merits hearing in the above-named matter. The merits hearing will continue on December 5, 6, 7, 8, 11, 14, 15, 2023, January 29, 30, 31, 2024 and February 1, 5 and 6, 2024 at 10:00 a.m. [&h
PSE&G Files Clean Energy Future – Energy Efficiency II (“CEF-EE II”) Program Advancing New Jersey’s Energy Efficiency, Building Decarbonization and Economic Growth
Comprehensive Energy Efficiency II Program Targets Reduction of Nearly 10 Million Metric Tons of Carbon Emissions, Emphasizing Lower Energy Usage and Costs for Participating Customers NEWARK, N.J. , Dec. 1, 2023 /PRNewswire/ — Today, PSE&G submitted its Clean Energy Future – Energy Eff
DIAMONDROCK HOSPITALITY COMPANY DECLARES DIVIDENDS FOR FOURTH QUARTER 2023
BETHESDA, Md., Dec. 1, 2023 /PRNewswire/ — DiamondRock Hospitality Company (the “Company”) (NYSE: DRH) announced that its Board of Directors has declared a cash dividend of $0.03 per common share. The dividend is payable on January 11, 2024 to shareholders of record as of December
Shanghai prioritizes efforts to improve people’s livelihood
BEIJING, Dec. 1, 2023 /PRNewswire/ — A report from People’s Daily: Chinese President Xi Jinping inspected a government-subsidized rental housing community and learned about the city’s efforts in constructing government-subsidized rental housing projects in Shanghai on Nov. 29. It i
HLLY Investors Have Opportunity to Lead Holley Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 1, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Holley Inc. (“Holley” or the “Company”) (NYSE: HLLY). Class Period: Jul
FDA Roundup: December 1, 2023
SILVER SPRING, Md., Dec. 1, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA rolled out new tools and FAQs to continue to inform stakeholders about the Food Traceability Rule and help
Yangtze River Delta advances high-quality integrated development
BEIJING, Dec. 1, 2023 /PRNewswire/ — A report from People’s Daily: The Yangtze River Delta is one of the most economically vibrant, open and innovative regions in China. It encompasses four major economic engines – Shanghai, Jiangsu, Zhejiang and Anhui. Shanghai serves as a fronti
United States Condom Market Analysis Report 2023-2028: Vegan Condoms Gain Traction, Rapid Increase in STIs, and Female Demand Drives Significant Growth
DUBLIN, Dec. 1, 2023 /PRNewswire/ — The “United States Condom Market Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. United States Condom Market is projected to reach a value of $723 million by 2028 from $412 milli
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have received at least two lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor, achieved an overall
